logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-104. New clients entering inpatient treatment by primary drug and age, 2010 or most recent year available

Part (vi) New volatile inhalant inpatient clients by country and age

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium100000000000
Bulgaria00000000000
Czech Republic01100000202
Denmark00000000000
Germany01100100303
Estonia:::::::::::
Ireland00000000000
Greece00000000000
Spain:::::::::::
France:::::::::::
Italy:::::::::::
Cyprus00000000000
Latvia:::::::::::
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary00000000000
Malta:::::::::::
Netherlands00000010101
Austria00000000000
Poland201000100202
Portugal:::::::::::
Romania0536000014014
Slovenia:::::::::::
Slovakia2824110018018
Finland00000000000
Sweden00000001101
Uk300101000202
Croatia:::::::::::
Turkey7763320126411590159
Norway:::::::::::
Total9924130149522020202
 

Notes:

: Indicates no data are available.

(1) In Belgium if the exact primary drug is not known, the generic category is recorded. In 2010 there were 96 Opiates, 1 Cocaine and 1 Hypnotics and Sedatives clients with the primary exact drug unknown. Of which 3 and 1 were new clients for respectively Opiates and Cocaine.

(2) Data are from 2009. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(3) Data are from 1st of April 2009 to 31st March 2010.

See also 'tdi-10-p12345678-07-Age distribution summary.xls' 'partv',' partvi' and 'General notes for interpreting data' on the Explanatory notes and help page.

Source:

2011 REITOX National Reports - Table TDI Inpatient Treatment Centres

Page last updated: Monday, 12 November 2012